Announcements Trials
Browse Landscape Eligibility

Clinical Trials

6 trials
RecentStart dateEnrollment
Adult × Clear all

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Recruiting 5Completed 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 11735Neoplasms 9361Carcinoma, Non-Small-Cell Lung 6100Prostatic Neoplasms 5640Colorectal Neoplasms 5275Lung Neoplasms 4518Multiple Myeloma 3186Pancreatic Neoplasms 3174Neoplasm Metastasis 3120Leukemia, Myeloid, Acute 3104Carcinoma, Hepatocellular 2907Ovarian Neoplasms 2832Melanoma 2805Stomach Neoplasms 2722Lymphoma 2681Head and Neck Neoplasms 2313Recurrence 2268Precursor Cell Lymphoblastic Leukemia-Lymphoma 2207Leukemia 2131Brain Neoplasms 2099Colonic Neoplasms 2065Lymphoma, Non-Hodgkin 2019Rectal Neoplasms 1955Uterine Cervical Neoplasms 1910Glioblastoma 1813Leukemia, Lymphocytic, Chronic, B-Cell 1776Carcinoma, Renal Cell 1700Squamous Cell Carcinoma of Head and Neck 1651Lymphoma, Follicular 1631Esophageal Neoplasms 1603

Interventions

dimethyl-2-(tetrahydro-2-furanyl)ethylsulfonium 1Gemcitabine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT06077903 2025-02-21

GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors

Grit Biotechnology

Phase EARLY_PHASE1 Recruiting
20 enrolled

Adult

NCT06191900 2025-02-17

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer)

Grit Biotechnology

Phase NA Recruiting
26 enrolled

Adult

NCT06453057 2025-02-17

Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Solid Tumours

Grit Biotechnology

Phase NA Recruiting
18 enrolled

Adult

NCT06819280 2025-02-17

Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Advanced Colorectal Cancer

Grit Biotechnology

Phase NA Recruiting
18 enrolled

Adult

NCT06241781 2025-02-07

Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients with Recurrent or Metastatic Cervical Cancer

Grit Biotechnology

Phase 2 Recruiting
83 enrolled

Adult

NCT00052273 2020-08-03

LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors

Jonsson Comprehensive Cancer Center

Phase 1 Completed
16 enrolled
Other solid neoplasm

Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡